JPRN-jRCT2080220752未知2 期
K012 phase II clinical study
ippon Kayaku Co., Ltd.0 个研究点开始时间: 2009年6月17日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 <= 74age old（—）
- 性别
- All
入选标准
- •1.Histologically confirmed colorectal cancer
- •2.Patients who have failed previous oxaliplatin-based chemotherapies
- •3.Presence of at least one unidimensionally measurable lesion
- •4.Performance Status 0-2
排除标准
- 未提供
研究者
相似试验
已完成
2 期
K-163-SZ Phase2 placebo-controlled studySchizophrenia with negative symptomsJPRN-jRCT2080223724Kowa Co., Ltd.80
已完成
2 期
A phase II clinical trial (KSCC/HGCSG/CCOG/PerSeUS1501A)examining oxaliplatin + S-1 for treatment of HER2-negative advanced/recurrent gastric cancer previously untreated with chemotherapyGastric CancerJPRN-UMIN000017550Kyushu Study group of Clinical Cancer70
招募中
2 期
Cladribine therapy in MyastheniaMyasthenia gravis2024-517083-32-00Uniwersytet Medyczny W Lublinie200
招募中
2 期
Phase II clinical trial on clinical efficacy and safety of combination therapy of boron neutron capture therapy and bevacizumab for recurrent glioma with poor prognosisRecurrent malignant gliomaJPRN-UMIN000029144Osaka Medical College20
未知
2 期
TK-FT Phase 2 Study (Efficacy and Safety Study)Breakthrough cancer painJPRN-jRCT2080220503TEIKOKU SEIYAKU CO., LTD.50